These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 25876880)

  • 1. Self-reported calcium use in a cohort of postmenopausal women receiving osteoporosis therapy: results from POSSIBLE US™.
    Barrett-Connor E; Wade SW; Downs RW; Ganiats T; Hochberg M; Recker RR; Stolshek BS
    Osteoporos Int; 2015 Aug; 26(8):2175-84. PubMed ID: 25876880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of medication adherence on health care utilization and productivity: self-reported data from a cohort of postmenopausal women on osteoporosis therapy.
    Wade SW; Satram-Hoang S; Nadkar A; Macarios D; Tosteson AN
    Clin Ther; 2011 Dec; 33(12):2006-15. PubMed ID: 22099387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term persistence and switching patterns among women using osteoporosis therapies: 24- and 36-month results from POSSIBLE US™.
    Wade SW; Satram-Hoang S; Stolshek BS
    Osteoporos Int; 2014 Sep; 25(9):2279-90. PubMed ID: 24942502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment satisfaction and persistence among postmenopausal women on osteoporosis medications: 12-month results from POSSIBLE US™.
    Barrett-Connor E; Wade SW; Do TP; Satram-Hoang S; Stewart R; Gao G; Macarios D
    Osteoporos Int; 2012 Feb; 23(2):733-41. PubMed ID: 21625886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physician differences in managing postmenopausal osteoporosis: results from the POSSIBLE US™ treatment registry study.
    Lukert B; Satram-Hoang S; Wade S; Anthony M; Gao G; Downs R
    Drugs Aging; 2011 Sep; 28(9):713-27. PubMed ID: 21913737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design of the POSSIBLE UStrade mark Study: postmenopausal women's compliance and persistence with osteoporosis medications.
    Barrett-Connor E; Ensrud K; Tosteson AN; Varon SF; Anthony M; Daizadeh N; Wade S
    Osteoporos Int; 2009 Mar; 20(3):463-72. PubMed ID: 18607669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequency of discontinuation of injectable osteoporosis therapies in US patients over 2 years.
    Modi A; Sajjan S; Insinga R; Weaver J; Lewiecki EM; Harris ST
    Osteoporos Int; 2017 Apr; 28(4):1355-1363. PubMed ID: 28058444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of GI events on persistence and adherence to osteoporosis treatment: 3-, 6-, and 12-month findings in the MUSIC-OS study.
    Modi A; Sen S; Adachi JD; Adami S; Cortet B; Cooper AL; Geusens P; Mellström D; Weaver JP; van den Bergh JP; Keown P; Sajjan S
    Osteoporos Int; 2018 Feb; 29(2):329-337. PubMed ID: 29110061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased treatment persistence and its determinants in women with osteoporosis with prior fracture compared to those without fracture.
    Jacob L; Dreher M; Kostev K; Hadji P
    Osteoporos Int; 2016 Mar; 27(3):963-969. PubMed ID: 26519418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Persistence and switching patterns among women with varied osteoporosis medication histories: 12-month results from POSSIBLE US.
    Tosteson AN; Do TP; Wade SW; Anthony MS; Downs RW
    Osteoporos Int; 2010 Oct; 21(10):1769-80. PubMed ID: 20101492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Persistence, adherence, and medication-taking behavior in women with postmenopausal osteoporosis receiving denosumab in routine practice in Germany, Austria, Greece, and Belgium: 12-month results from a European non-interventional study.
    Hadji P; Papaioannou N; Gielen E; Feudjo Tepie M; Zhang E; Frieling I; Geusens P; Makras P; Resch H; Möller G; Kalouche-Khalil L; Fahrleitner-Pammer A
    Osteoporos Int; 2015 Oct; 26(10):2479-89. PubMed ID: 26018090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medication persistence in older women with osteoporosis: a pilot study.
    Gillette C; Howerton DM; Williams BD; Mahmood MA
    Osteoporos Int; 2015 Dec; 26(12):2883-8. PubMed ID: 26194492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determinants of adherence to osteoporosis treatment in clinical practice.
    Rossini M; Bianchi G; Di Munno O; Giannini S; Minisola S; Sinigaglia L; Adami S;
    Osteoporos Int; 2006; 17(6):914-21. PubMed ID: 16538553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term persistence with anti-osteoporosis drugs after fracture.
    Klop C; Welsing PM; Elders PJ; Overbeek JA; Souverein PC; Burden AM; van Onzenoort HA; Leufkens HG; Bijlsma JW; de Vries F
    Osteoporos Int; 2015 Jun; 26(6):1831-40. PubMed ID: 25822104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low persistence with oral biphosphonate treatment in postmenopausal osteoporosis.
    Torre C; Guerreiro J; Mendes Z; Miranda A; Bragança F; Cristino J; Canhão H; Branco JC
    Acta Reumatol Port; 2019; 44(2):114-125. PubMed ID: 31280276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Compliance with osteoporosis treatment guidelines in postmenopausal women.
    Mountjoy CR; Shrader SP; Ragucci KR
    Ann Pharmacother; 2009 Feb; 43(2):242-50. PubMed ID: 19196838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gastrointestinal side effects in postmenopausal women using osteoporosis therapy: 1-year findings in the POSSIBLE US study.
    Woo C; Gao G; Wade S; Hochberg MC
    Curr Med Res Opin; 2010 Apr; 26(4):1003-9. PubMed ID: 20201623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Switch patterns of osteoporosis medication and its impact on persistence among postmenopausal women in the U.K. General Practice Research Database.
    Li L; Roddam A; Ferguson S; Feudjo-Tepie M; Taylor A; Jick S
    Menopause; 2014 Oct; 21(10):1106-13. PubMed ID: 24569621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Analysis of therapeutic compliance in women with osteoporosis].
    Carbonell Abella C; Guañabens Gay N; Regadera Anechina L; Marín Rives JA; Taverna Llauradó E; Ayechu Redín MP;
    Reumatol Clin; 2011; 7(5):299-304. PubMed ID: 21925445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone health and adherence to vitamin D and calcium therapy in early breast cancer patients on endocrine therapy with aromatase inhibitors.
    Bošković L; Gašparić M; Petković M; Gugić D; Lovasić IB; Soldić Ž; Miše BP; Dabelić N; Vazdar L; Vrdoljak E
    Breast; 2017 Feb; 31():16-19. PubMed ID: 27810693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.